Growth Metrics

CareDx (CDNA) Gross Profit (2016 - 2026)

CareDx's Gross Profit history spans 14 years, with the latest figure at $87.3 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 41.55% to $87.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $302.8 million, a 15.89% increase, with the full-year FY2025 number at $277.2 million, up 10.07% from a year prior.
  • Gross Profit hit $87.3 million in Q1 2026 for CareDx, up from $77.5 million in the prior quarter.
  • Over the last five years, Gross Profit for CDNA hit a ceiling of $87.3 million in Q1 2026 and a floor of $44.8 million in Q4 2023.
  • Historically, Gross Profit has averaged $61.1 million across 5 years, with a median of $58.7 million in 2022.
  • Biggest five-year swings in Gross Profit: decreased 23.63% in 2023 and later soared 46.44% in 2024.
  • Tracing CDNA's Gross Profit over 5 years: stood at $58.7 million in 2022, then decreased by 23.63% to $44.8 million in 2023, then soared by 45.48% to $65.2 million in 2024, then increased by 18.74% to $77.5 million in 2025, then grew by 12.74% to $87.3 million in 2026.
  • Business Quant data shows Gross Profit for CDNA at $87.3 million in Q1 2026, $77.5 million in Q4 2025, and $75.6 million in Q3 2025.